Show Us the Money: Lessons in Transparency From State Pharmaceutical Marketing Disclosure Laws
Rozario, Natassia M
Rothman, David J
Health services research 2010 Feb ; 45(1): 98-114
OBJECTIVE: To assess legislation requiring drug companies to report gifts to providers, and to evaluate the information obtained. DATA SOURCES: Data included legislation in Vermont, Minnesota, Maine, Massachusetts, West Virginia, and the District of Columbia, and company disclosure data from Vermont. STUDY DESIGN: We evaluated the strengths and weaknesses of state legislation. We also analyzed 4 years of company disclosures from Vermont, assessing the value and distribution of industry-provider exchanges and identifying emerging trends in companies' practices. DATA COLLECTION METHODS: State legislation is publically available. We obtained Vermont's data through requests to the state's Attorney General's office. PRINCIPAL FINDINGS: Of the state laws, only Vermont's yielded robust, publically available data. These data show gifting was dominated by a few major corporations, and
Showing items related by title, author, creator and subject.
Chimonas, Susan; Frosch, Zachary; Rothman, David J (2011-01-10)It has become standard practice in medical journals to require authors to disclose their relationships with industry. However, these requirements vary among journals and often lack specificity. As a result, disclosures may ...